about
JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinomaSoluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicinp53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinomaImmunobiology of hepatocarcinogenesis: Ways to go or almost there?Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesisEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaTargeting the insulin-like growth factor pathway in hepatocellular carcinomaRecognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionRegulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR systemA novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeSuppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor beta dependent.Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methodsTherapy and prognostic features of primary clear cell carcinoma of the liverInduction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells.Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma.Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.Notch1 binds and induces degradation of Snail in hepatocellular carcinoma.Bioinformatics analysis reveals potential candidate drugs for HCC.γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling.Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case reportDihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells.RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma.Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinomaFarnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3.Cancer stem cells in hepatocellular carcinoma--an immunohistochemical study with histopathological association.Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safetyMetallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade.Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Sorafenib for treatment of hepatocellular carcinoma: a systematic review.New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.Hepatocellular carcinoma: management of an increasingly common problemA meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma.Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines
P2860
Q23919676-E180CC37-B782-45F8-BBFC-D3D664EB39C0Q24292953-F449671E-F157-4E0E-AB61-6E902C391FD2Q24306453-EFBA63FE-AEC4-483E-90BF-EBFD5DDF6BFBQ26738293-BD7317EE-1A29-4A3B-B3C3-F2F6FE72B0D0Q26823512-9C533523-14E6-46CC-9246-326199185222Q26849546-D2625359-6724-4B0C-941C-69CCCA18C20CQ27006846-3B7E5088-5024-4AC7-8B06-C22113EA759CQ27311035-0C9AEC94-8BF8-4F9E-BB57-D64D9BAF431EQ28484499-0B01B4BC-9EFD-4FA0-90CE-2C25A351B8CBQ28817910-F7141B5D-4645-45B7-961C-4078E514C767Q33259095-9D86252A-BE8F-4235-8014-C5350408B187Q33312870-C757F4D5-A05B-42A2-B60C-5A6CEB4A960EQ33591504-A67D247E-26E2-4DF0-BE66-4DE8D969D4C3Q33632378-74039306-A259-48EC-88FF-D39021CA8831Q33706879-E63AC188-DBCC-4BE6-97F8-6A0885F4EE1DQ33864148-805992BF-F0D1-484B-A07C-7E624155C867Q33898809-25BFFCDF-094E-465F-9EAD-FB9B1E9D58B7Q34042354-34431526-4D8C-4773-81A7-0AA28F9A119FQ34086677-54EA2AEA-799F-4625-A4F7-E45A8FCC2026Q34557787-4138C219-A04A-4EF9-91B6-DC8275665BECQ34919598-9555BA49-E384-4F54-A567-4F8082EF0B70Q35041516-03047274-50D3-4870-B7C9-2753FD65EA60Q35169398-0464ABF8-FB56-450A-96CB-C6EBA1D38BA3Q35478306-87E4B13D-7BC4-4A36-B0B3-776775D91A84Q35620926-21543ABD-1C21-4C77-B786-638F8ABCB7ECQ35832116-79A9B0AA-AA2C-4959-A72B-589C9DEB6EF8Q36008156-5AC6C824-E666-4E86-8B48-E3E3BAFCD37AQ36230812-7DEDF126-19E2-4FEC-873F-F9DF7FB5620BQ36275798-F510AF2F-2E3F-42FF-9AC2-98F2F279CCC7Q36336233-576B6FC9-B185-4354-98C8-F40BCAE475F8Q36383646-4430E5C0-E456-419F-80FA-6D4D9CB58727Q36444510-5478CE9B-217D-408A-8F04-B8578EDBA305Q36512697-90F774A5-C661-491B-98DB-C07CB31DDBE1Q36566943-3CFBED03-AF16-47E0-8396-131BBE0175CBQ36680204-F9A0D311-7A62-4574-8A1D-1B3FD64BAF7DQ36740642-7423F1E0-2D02-4B95-B974-4B201B530034Q36746503-BF511990-979B-44DE-8748-BA14C68F5BD1Q36934253-425089AD-1169-48A9-8934-FAC0487FAE5AQ37012098-4D801CBA-4B71-4AE6-8338-58F22CF796E5Q37013811-9543B951-D8A8-4C27-95CD-9D4845F4385B
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
New therapies for hepatocellular carcinoma.
@ast
New therapies for hepatocellular carcinoma.
@en
type
label
New therapies for hepatocellular carcinoma.
@ast
New therapies for hepatocellular carcinoma.
@en
prefLabel
New therapies for hepatocellular carcinoma.
@ast
New therapies for hepatocellular carcinoma.
@en
P2093
P50
P356
P1433
P1476
New therapies for hepatocellular carcinoma
@en
P2093
P2888
P304
P356
10.1038/SJ.ONC.1209550
P407
P577
2006-06-01T00:00:00Z